Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitus

International Journal of Immunogenetics

Volumn 33, Issue 1, 2006, Pages 7-10

  Ni, R ^a   Ihara, K ^a   Miyako, K ^a   Takemoto, M ^a   Ishimura, M ^a   Kohno, H ^b   Matsuura, N ^c   Yoshimura, A ^d   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA CHILDREN S HOSPITAL   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BIOLOGICAL MARKER; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 5; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; JAPAN; MALE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 33645086880     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2006.00563.x     Document Type: Article

References (26)

1. Alexander W.S. Starr R. Fenner J.E. Scott C.L. Handman E. Sprigg N.S. et al. 1999 SOCS1 is a critical inhibitor of interferon-gamma signaling and prevents the potentially fatal neonatal actions of this cytokine Cell 98 597
2. Arakawa S. Hatano Y. Katagiri K. 2004 Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis Clinical and Experimental Immunology 135 505
3. Bassuny W.M. Ihara K. Kimura J. Ichikawa S. Kuromaru R. Miyako K. et al. 2003a Association study between interleukin-12 receptor beta1/beta2 genes and type 1 diabetes or asthma in the Japanese population Immunogenetics 55 189
4. Bassuny W.M. Ihara K. Sasaki Y. Kuromaru R. Kohno H. Matsuura N. Hara T. 2003b A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes Immunogenetics 55 149
5. Brender C. Columbus R. Metcalf D. Handman E. Starr R. Huntington N. et al. 2004 SOCS5 is expressed in primary B and T Lymphoid cells but is dispensable for lymphocyte production and function Molecular and Cellular Biology 24 6094
6. Chong M.M. Chen Y. Darwiche R. Dudek N.L. Irawaty W. Santamaria P. Allison J. Kay T.W. Thomas H.E. 2004 Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction Journal of Immunology 172 5714
7. Chong M.M. Thomas H.E. Kay T.W. 2002 Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor Journal of Biological Chemistry 277 27945
8. Egan P.J. Lawlor K.E. Alexander W.S. Wicks I.P. 2003 Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation Journal of Clinical Investigation 111 915
9. Elliott J. Johnston J.A. 2004 SOCS: role in inflammation, allergy and homeostasis Trends in Immunology 25 434
10. Flodstrom-Tullberg M. Yadav D. Hagerkvist R. Tsai D. Secrest P. Stotland A. Sarvetnick N. 2003 Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse Diabetes 52 2696
11. Fujimoto M. Naka T. 2003 Regulation of cytokine signaling by SOCS family molecules Trends in Immunology 24 659
12. Fujimoto M. Tsutsui H. Xinshou O. Tokumoto M. Watanabe D. Shima Y. et al. 2004 Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases International Immunology 16 303
13. Gylvin T. Nolsoe R. Hansen T. Nielsen E.M. Bergholdt R. Karlsen A.E. et al. 2004 Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in type 1 diabetes and insulin sensitivity Diabetologia 47 1273
14. Karlsen A.E. Ronn S.G. Lindberg K. Johannesen J. Galsgaard E.D. Pociot F. Nielsen J.H. Mandrup-Poulsen T. Nerup J. Billestrup N. 2001 Suppressor of cytokine signaling 3 (SOCS-3) protects beta-cells against interleukin-1beta- and interferon-gamma-mediated toxicity Proceedings of the National Academy of Sciences of the USA 98 12191
15. Kile B.T. Schulman B.A. Alexander W.S. Nicola N.A. Martin H.M. Hilton D.J. 2002 The SOCS box: a tale of destruction and degradation Trends in Biochemical Science 27 235
16. Marine J.-C. McKay C. Wang D. Topham D.J. Parganas E. Nakajima H. et al. 1999a SOCS3 is essential in the regulation of fetal liver erythropoiesis Cell 98 617
17. Marine J.-C. Topham D.J. McKay C. Wang D. Parganas E. Stravopodis D. Yoshimura A. Ihle J.N. 1999b SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality Cell 98 609
18. Matsuura N. Fukuda K. Okuno A. Harada S. Fukushima N. Koike A. Ito Y. Hotsubo T. 1998 Descriptive epidemiology of IDDM in Hokkaido, Japan: the Childhood IDDM Hokkaido Registry Diabetes Care 21 1632
19. Nicholson S.E. De Souza D. Fabri L.J. Corbin J. Willson T.A. Zhang J.G. Silva A. Asimakis M. Farley A. Nash A.D. 2000 Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 Proceedings of the National Academy of Sciences of the USA 97 6493
20. O'Shea J.J. Gadina M. Schreiber R.D. 2002 Cytokine signaling in 2002: new surprises in the JAK/STAT pathway Cell 109 Suppl. S121
21. Sasaki Y. Ihara K. Matsuura N. Kohno H. Nagafuchi S. Kuromaru R. et al. 2004 Identification of a novel type 1 diabetes susceptibility gene, T-bet Human Genetics 115 177
22. Schreiber S. Rosenstiel P. Hampe J. Nikolaus S. Groessner B. Schottelius A. Kuhbacher T. Hamling J. Folsch U.R. Seegert D. 2002 Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease Gut 51 379
23. Seki Y. Hayashi K. Matsumoto A. Seki N. Tsukada J. Ransom J. Naka T. Kishimoto T. Yoshimura A. Kubo M. 2002 Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation Proceedings of the National Academy of Sciences of the USA 99 13003
24. Seki Y. Inoue H. Nagata N. Hayashi K. Fukuyama S. Matsumoto K. et al. 2003 SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses Nature Medicine 9 1047
25. Starr R. Metcalf D. Elefanty A.G. Brysha M. Willson T.A. Nicola N.A. Hilton D.J. Alexander W.S. 1998 Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1 Proceedings of the National Academy of Sciences of the USA 95 14395
26. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1183